NSETrading Window28 Sept 2026 · 28 Sept 2026, 11:05 am
Trading Window
Indo Us Biotech Limited · INDOUS
✦ AI Summary
Indo Us Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Indo Us Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
INDOUS_28092026110525_Closing_of_Trading_Window_Indo_Us_Bio_Tech_Limited.pdf
View document text
Date: 28th September, 2026
BSE Limited National Stock Exchange of India Limited
Dept. of Corporate Services, Dept. of Corporate Compliances,
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1 Block-G,
Dalal Street, Bandra Kurla Complex,
Mumbai- 400 001 Bandra (E) Mumbai- 400 051
BSE Scrip Code - 541304 NSE Symbol: INDOUS
Dear Sir/Madam,
Sub: Intimation of Closure of Trading Window
Pursuant to the Company’s Code of Conduct for Prevention of Insider Trading framed in accordance with
SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to
inform that the trading window for dealing in the shares of the Company shall remain closed for all
Designated Persons of the Company from October 01, 2026 till completion of 48 hours from the
announcement of the unaudited financial results of the Company for the quarter and half year ending
September 30, 2026 to the Stock Exchanges.
The date of meeting of the Board of Directors to approve the un-audited financial results of the Company
for the quarter and half year ending ended September 30, 2026, shall be informed in due course.
Request you to take the same on your records.
Thanking you.
Yours faithfully,
For, Indo Us Bio Tech Limited
Ms. Dimpy Joshi
Company Secretary & Compliance Officer